Position in IQV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,546,853
+$3,735,254 QoQ
Shares Held
23,532
+394.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#325
of 1,077 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $42,339,129 across 32 Diagnostics & Research names. IQV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
56,486 | $9,931,933 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
12,159 | $6,096,036 | |
| 3 | NTRA |
Natera, Inc.
|
18,839 | $5,113,846 | |
| 4 | IQV |
Iqvia Holdings Inc.
This page
|
23,532 | $4,546,853 | |
| 5 | DHR |
Danaher Corp /De/
|
22,030 | $4,196,274 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
6,259 | $3,314,703 | |
| 7 | A |
Agilent Technologies, Inc.
|
19,198 | $2,550,070 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,735 | $913,373 |
All Filings in IQV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,546,853 | 23,532 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $811,599 | 4,759 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,815,677 | 8,055 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,308,253 | 27,947 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $269,794 | 1,712 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,603 | 253 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $87,839 | 447 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $40,995 | 173 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $25,372 | 120 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $4,166 | 23 | Shares | Sole | 2022-11-03 | |
| No filing history on record for this holder in this stock. | ||||||